Colposcopes Market Share, Insight, Report, Trends, Analysis, & Forecast

SKU: DMPH2384 | Last Updated On: May 13 2022 | Available Formats

> Global Colposcopes Market Expected to reach at a high CAGR of ~6.4% by 2029: DataM Intelligence

Global Colposcopes Market is segmented By Instrument Type (Optical Colposcope, Digital Colposcope), By Instrument Portability (Stationary, Handheld), By Application (Cervical Cancer Screening, Physical Examinations, Others), By End-Users (Hospitals, Clinics, Diagnostic centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Colposcopes Market Size Trends Growth Rate Outlook 2022-2029

The Colposcopes Market is expected to grow at a high CAGR of ~6.4% during the forecasting period (2022-2029). Colposcopes are medical instrument used to magnify the cells of the cervix and vagina. These devices are used to diagnose cervical cancer, vaginal cancer, and inflammation of the cervix. Colposcopes are comprised of a high-resolution camera and electronic green filter for observing the vagina or cervical cells on the screen.

Significant elements that are driving the global market growth such as an increase in awareness among individuals on early identification of the diseases, a rise in occurrences of cervical cancer, and the availability of new products. Furthermore, colposcopy is painless, non-invasive process, with no blood loss, and it is more expensive that more effective than demand worldwide. Furthermore increased demand for colposcopies between emerging countries and an increase in uptake of colposcopies for monitoring gynecological disorders are added factors that donate toward the global market growth.

Asia Pacific Colposcopes Market shows profitable opportunities for major companies leading in the market for colposcopes. The surge in consciousness about the initial screening of diseases and increase in acceptance of colposcopes products is projected to lead to market growth in the Asia Pacific region. North America region is producing a major share in the global Colposcopes Market during the forecast period 2022-2029.

Colposcopes Market Scope



Market CAGR


Segments Covered

By Instrument Type, By Instrument Portability, By Application, By End User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Market Dynamics:

The market is driven by the rising demand for Colposcopes with the rising incidence of Cervical Cancer. According to the World Cancer Research Fund Organization, Cervical Cancer is the fourth most commonly occurring cancer in women and the eighth-most commonly occurring cancer overall worldwide. According to the World Health Organization (WHO), approximately 570,000 incident cases of Cervical Cancer were observed worldwide in 2018. Around 90% of deaths from Cervical Cancer occurred in low-and middle-income countries. Approximately 266,000 women died due to Cervical Cancer in 2012.

The rise in the approval & launch of the novel products shall stimulate market growth. For instance, in August 2016, CardiacDirect had launched the GT-30 and GT-60 video colposcopes to its growing product portfolio. These colposcopes feature the innovative R-way Evaluation Program that provides gynecologists with an advanced examination system and guidance for cervical disease diagnosis. The GT-30 and GT-60 Video Colposcope feature a full-screen display that provides a superior level of accuracy and is equipped with a high-resolution camera and a cold LED lighting system for zero heat transfer to the patient.

The market is witnessing technological advancement with the digital platform for the development of colposcopes. For instance, in August 2016, MobileODT had received approval for the Enhanced Visual Assessment (EVA) System, a mobile phone-based connected colposcope. It enables the rural health providers and health providers in low resource settings to benefit from the cost-effective, internet-connected power of a robust video colposcope. It is a mobile, connected, easy-to-use device adopted by an increasing number of organizations operating in over 21 countries to strengthen cervical cancer screening programs' capacity and quality. It allows for visualization of the cervix, remote support of providers by clinical supervisors, quality assurance and reporting functions, patient follow-up tracking, and the integration of records into electronic health record systems.

The rise in the organizations, associations, and institutes initiatives for raising awareness regarding Cervical Cancer Prevention and Control shall positively impact the market. For instance, 7 UN agencies under the United Nations Task Force on NCDs have positively impacting Programme to prevent and control Cervical Cancer. It aims at providing the diagnosis and treatment of invasive cervical cancer to all women, screening and treatment for cervical pre-cancer available for women, and Human papillomavirus immunization for girls.

Several organizations, associations, and institutes are entering into a collaboration with the companies to develop colposcopes. In 2017, Duke University had entered into the collaboration with 3rd Stone Design, Inc to develop a beta prototype of the Pocket Colposcope. It is less expensive, smaller in size, and lighter than traditional clinical colposcope devices.

However, the high cost of colposcopes shall hinder market growth. Moreover, the availability of alternative methods for detecting cervical and vaginal cancer, such as Pap smear tests and HPV tests, could hurt the colposcopes market.

Segment Analysis

The colposcopes market is segmented on instrument types such as optical colposcopes and digital colposcopes. The optical colposcope segment is expected to have the highest market share owing to the high adoption of optical colposcopes, especially in developing countries, due to their cost-effectiveness easy installation, ease of examination, and require, especially in. It is further expected that the optical colposcope segment would lose the market over the d period owing to the introduction of digital colposcopes.

The digital colposcope segment is expected to have positive market growth due to the rising digital colposcope development with high definition camera and imaging module used for clinic due to the rising digital colposcope developmental colposcopes provide advanced features including data management, high-quality images, and improved capability for cervical cancer screening. The market is witnessing the launch of the novel digital colposcope for the diagnosis of Cervical Cancer. For instance, in 2017, DYSIS Medical had launched the latest-generation DYSIS Ultra colposcope. This colposcope would help the clinicians in the in vivo evaluation, documentation, and follow-up of cervical pathology. It images the cervix and lowers the genital tract under illumination and magnification. In 2015, Bovie Medical Corporation had introduced a new Colpo-Master Colposcopes line, a perfect addition to the already popular line of gynecologic products, including superior, 3D, stereoscopic viewing with excellent clarity during gynecologic procedures where millimeters matter. These devices are available with a consistent and dependable zoom range, including simple 3 point magnification (3.75x, 7.5x, and 15x) or continuous zoom 4 – 27x magnification.

Further, the colposcopes market is also classified based on portability as stationary and handheld. The stationary segment accounts for the highest market share due to stationary colposcopes' availability at a low price. These are widely used in hospitals and clinics due to the stationary colposcopes. Further expected that the stationary segment should lose its market due to the growing preference for handheld colposcopes.

The handheld segment is expected to witness the fastest market growth over the forecasted period owing to the growing adoption of the handheld colposcopes due to their benefits such as simple interface, improved workflow, enhanced clinical services, superior monitoring capabilities, and advanced modes. The market is witnessing the launch of the new handheld colposcopes with improved image contrast levels. For instance, in April 2018, MobileODT had launched an advanced EVA 3 Plus mobile colposcope for cervical cancer screenings and sexual assault forensic examinations. EVA 3 Plus is packed with new features, including a larger screen, higher resolution images, and a brighter LED illumination. It is further expected that the handheld segment shall dominate the market growth over the forecasted period.

Geographical Presentation

By region, the colposcopes market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the colposcopes market due to the higher adoption of colposcopes with the increasing prevalence of Cervical Cancer and Vaginal Cancer. According to the Surveillance, Epidemiology, and End Results Program, approximately 13,800 incident Cervical Cancer cases are expected to be observed in 2020 in the United States. Cervical Cancer is the leading cause of cancer death for women in the United States. Around 4,290 women died due to Cervical Cancer in 2020. According to the Centres for Disease Control and Prevention (CDC), around 1,293 women, i.e., 0.6 per 100,000 women, were diagnosed with Vaginal Cancer in 2016. The United States accounts for the highest market share of XX% owing to the high technological advancement, including integrating digital platforms with the colposcopes to stimulate market growth. The ongoing development of colposcopes with high resolution would replace the traditional colposcopes. The North America region is expected to maintain its dominant position over the forecasted period.

The Asia Pacific region is expected to have positive market growth owing to the rising aging population as the older population is at high risk of developing Cervical Cancer. There is a growing penetration of medical imaging technology and improved healthcare facilities, including advanced medical facilities. Several market players are expanding their presence in the Asia Pacific market. Moreover, the rising government spending on gynecological disorders shall boost the demand for colposcopes. Substantial growth is expected to be observed in developing countries owing to the higher incidence rate and mortality rate of Cervical Cancer. The increasing awareness regarding the early diagnosis of Cervical Cancer and Vaginal Cancer shall positively impact the market. For instance, in December 2017, Cancer Institute NSW of Australia, a state-wide positive impacter control agency, had renewed National Cervical Screening Program to reduce the incidence and mortality caused by cervical cancer by organizing screening programs. It involves the primary human papillomavirus (HPV) screening every 5 years for women aged 25–69 years and exit testing for women aged 70–74 years, with partial genotyping for HPV types 16 and 18 and liquid-based cytology triage for other HPV types.

Competitive Analysis

The colposcopes market is highly competitive with the presence of several international and local market players. Product diversification, technological advancement, revenue generation, and opportunities intensify the market competition. Carl Zeiss AG, Olympus Corporation, Danaher Corporation, Cooper Surgical, Inc, McKesson Corporation, DYSIS Medical, and Karl Kaps Gmbh & Co. Kg are the leading Market players with significant market share.

Companies are using novel product launches, technological advancements, new product development, and market expansion strategies for holding their position in the market. For instance, In June 2019, MobileODT had received the 2019 FT/IFC Transformational Business Award in Health, Wellness, and Disease Prevention. In August 2019, MobileODT had received an Innovative Technology contract from Vizient, Inc. for the EVA System, an FDA-cleared smart mobile colposcope for the assessment and diagnosis of cervical cancer and use in forensic examination by Sexual Assault Nurse Examiners.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for Colposcopes Market and their expansion across the globe. For instance, in August 2018, Specialty Surgical Instrumentation Inc. (a subsidiary of Symmetry Surgical Inc.) had acquired the Core business segment, i.e., the Electrosurgical segment of Bovie Medical. The Electrosurgical segment includes the generators, electrodes, cauteries, lighting, colposcopes, accessories, and the Bovie brand.

The companies are raising the funding and investment for the development of colposcopes. For instance, in July 2018, DYSIS Medical had completed a $25 million (£18 million) investment to accelerate the growth of its DYSIS Ultra colposcope used in cervical cancer screening. The colposcope uses optical and software techniques to scan a patient’s cervix, quantify the results, and present them to a clinician in the form of an intuitive color-coded map (DYSISmap). The map can be easily shown and explained during an examination, improving understanding and reducing anxiety.

**The global colposcopes market report will provide access to approximately 53 Market data tables, 44 figures, and 180 pages

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Trending Topics

Endoscopes Market

Resectoscopes Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!